
Moderna's mRNA Flu Vaccine Outperforms Traditional Shot in Breakthrough Trial
Moderna's mRNA flu vaccine outperforms traditional shots in Phase 3 trial, marking a significant milestone in seasonal flu prevention.
Moderna's mRNA flu vaccine outperforms traditional shots in Phase 3 trial, marking a significant milestone in seasonal flu prevention.